ARTICLE | Company News
FDA approves GE's AdreView
September 20, 2008 2:05 AM UTC
FDA approved an NDA from General Electric (NYSE:GE) for AdreView as a molecular imaging agent to detect neuroendocrine tumors. The company plans to launch the iobenguane I 123 injection, which has Orp...